确保全球获得COVID-19疫苗的挑战:生产,负担能力,分配和部署
Olivier J Wouters1, Kenneth C Shadlen2, Maximilian Salcher-Konrad1
1Department of Health Policy, London School of Economics and Political Science, London, UK.
Lancet (London, England)
|February 15, 2021
概括
全球疫苗推广对于结束COVID-19大流行至关重要. 本研究分析了候选疫苗,并确定了生产,定价和分配方面的挑战,以实现公平的获取和群体免疫力.
科学领域:
- 公共卫生
- 疫苗学
- 卫生政策
背景情况:
- COVID-19 大流行需要全球疫苗推出以控制和群体免疫力.
- 虽然疫苗得到批准,但大规模生产,可负担性,全球分配和社区部署仍然存在挑战.
研究的目的:
- 审查全球COVID-19疫苗取得成功的挑战.
- 分析26种主要候选疫苗的关键特征.
- 评估不同国家可能接受的疫苗.
主要方法:
- 根据有效性,剂量,储存,价格,生产能力和低收入国家的分配,开发了一个仪表板来评估26种候选疫苗.
- 使用交通信号系统向全球免疫贡献信号.
- 对32个国家 (n=26,758) 进行了关于COVID-19疫苗接受度的调查 (2020年10月至12月).
主要成果:
- 该仪表板强调了政策制定者在疫苗选择和计划实施方面的权衡.
- 疫苗接受率因国家而异,越南 (98%) 和印度 (91%) 的接受率最高,塞尔维亚 (38%) 和克罗地亚 (41%) 的接受率最低.
结论:
- 应对疫苗生产,公平分配和部署方面的挑战对于全球COVID-19控制至关重要.
- 了解具体国家对疫苗的接受度对于成功实施疫苗接种计划至关重要.
更多相关视频
相关概念视频
Issues And Trends In Healthcare Delivery System
6.0K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.0K
International Nursing Organizations II
1.2K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.2K
Methods Of Healthcare Delivery System
3.7K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.7K
Introduction To Health Care Delivery System
3.5K
The healthcare system is constantly changing and complex. Various services are available from different healthcare providers, but gaining access to these services has become challenging for people with limited healthcare insurance. Uninsured people present a challenge to healthcare because they frequently postpone or forego treatment.
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
3.5K
Drug Control Governance: Regulatory Bodies and Their Impact
354
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
354
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
60
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
60


